摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(1-Hydroxy-but-3-en-1-yl)-2-methoxypyridine | 146949-43-1

中文名称
——
中文别名
——
英文名称
3-(1-Hydroxy-but-3-en-1-yl)-2-methoxypyridine
英文别名
1-(2-methoxypyridin-3-yl)but-3-en-1-ol
3-(1-Hydroxy-but-3-en-1-yl)-2-methoxypyridine化学式
CAS
146949-43-1
化学式
C10H13NO2
mdl
——
分子量
179.219
InChiKey
PZRNOSADWBWFRI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    42.4
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-(1-Hydroxy-but-3-en-1-yl)-2-methoxypyridine二氯甲烷氯化亚砜二氯甲烷氯化亚砜碳酸氢钠 作用下, 反应 16.0h, 以59.3 g of the crude title compound are obtained as an oil的产率得到3-(1-Chloro-but-3-en-1-yl)-2-methoxypyridine
    参考文献:
    名称:
    Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use
    摘要:
    氨甲基取代的2,3-二氢吡喃并[2,3-b]吡啶可以通过对应胺的烷基化制备。这种新型氨甲基取代的二氢吡喃并[2,3-b]吡啶可以作为药物的活性成分,特别是用于治疗中枢神经系统疾病。
    公开号:
    US05250540A1
  • 作为产物:
    参考文献:
    名称:
    [EN] SMALL MOLECULE MODULATORS OF IL-17
    [FR] MODULATEURS À PETITES MOLÉCULES D'IL-17
    摘要:
    The present invention relates to a compound according to formula (I), and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
    公开号:
    WO2023111181A1
点击查看最新优质反应信息

文献信息

  • Aminomethyl-substituierte 2,3-Dihydropyrano(2,3-b)pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
    申请人:BAYER AG
    公开号:EP0519291B1
    公开(公告)日:1997-01-08
  • US5250540A
    申请人:——
    公开号:US5250540A
    公开(公告)日:1993-10-05
  • Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use
    申请人:Bayer Aktiengesellschaft
    公开号:US05250540A1
    公开(公告)日:1993-10-05
    Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines can be prepared by alkylation of corresponding amines. The novel aminomethyl-substituted dihydropyrano[2,3-b]pyridines can be used as active ingredients in medicaments, in particular for the treatment of disorders of the central nervous system.
    含氨基甲基取代的2,3-二氢吡喃[2,3-b]吡啶可以通过相应胺的烷基化制备。这种新型的含氨基甲基取代的二氢吡喃[2,3-b]吡啶可以作为药物的活性成分,特别用于治疗中枢神经系统疾病。
  • [EN] SMALL MOLECULE MODULATORS OF IL-17<br/>[FR] MODULATEURS À PETITES MOLÉCULES D'IL-17
    申请人:[en]LEO PHARMA A/S
    公开号:WO2023111181A1
    公开(公告)日:2023-06-22
    The present invention relates to a compound according to formula (I), and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
查看更多